Gossamer Bio, Inc. (GOSS) stock
GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$11.04+0.06 (+0.55%)
Close on Nov 17, 2026Market cap $5.40BP/E –Yield –
Gossamer Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Gossamer Bio's price to sales ratio was 1.3× on Nov 11, 2026, against 17.5× a year earlier. Over the last 2 years it ranged from 0.7× to 17.5×, with a median of 2.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | −14.9 |
| 2025 | Dec 31, 2025 | 16.3× | +14.3 |
| 2024 | Dec 31, 2024 | 1.9× | – |
See a number that looks wrong?